Chimeric Therapeutics (ASX:CHM) Buyback Yield % : -104.17 (As of Apr. 26, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Chimeric Therapeutics Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Chimeric Therapeutics's current buyback yield was -104.17%.

Chimeric Therapeutics Buyback Yield % Historical Data

The historical data trend for Chimeric Therapeutics's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chimeric Therapeutics Buyback Yield % Chart

Chimeric Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Buyback Yield %

-64.09

-34.73

-12.92

-60.18

Chimeric Therapeutics Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buyback Yield %	Get a 7-Day Free Trial			-	-12.92	-26.69	-60.18	-76.54

Competitive Comparison of Chimeric Therapeutics's Buyback Yield %

For the Biotechnology subindustry, Chimeric Therapeutics's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chimeric Therapeutics's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chimeric Therapeutics's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Chimeric Therapeutics's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Chimeric Therapeutics Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Chimeric Therapeutics's Buyback Yield for the fiscal year that ended in Jun. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (-1.196	+	11.74)	/	17.520535326
	=	-60.18%

Chimeric Therapeutics's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (-0.733	+	9.172)		/	11.024944062
	=	-76.54%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Chimeric Therapeutics Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Chimeric Therapeutics's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Chimeric Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chimeric Therapeutics Ltd (ASX:CHM) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.chimerictherapeutics.com

Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the tumor-targeting component of the CAR to reprogram T cells. Primary products under development by the company are NK Cell Derived Allogenic Therapies and T Cell Derived Autologous Therapies. The company has one segment being the research, development and commercialization of health technologies.

Chimeric Therapeutics Headlines

No Headlines